Skip to main content
Top
Published in: Diabetologia 3/2013

01-03-2013 | Article

HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus

Authors: R. Strollo, P. Rizzo, M. Spoletini, R. Landy, C. Hughes, F. Ponchel, N. Napoli, A. Palermo, R. Buzzetti, P. Pozzilli, A. Nissim

Published in: Diabetologia | Issue 3/2013

Login to get access

Abstract

Aims/hypothesis

In this study the involvement of oxidative stress in type 1 diabetes mellitus autoimmunity and the possible association with rheumatoid arthritis (RA) was investigated. We tested the hypothesis that oxidative stress induced by chronic hyperglycaemia triggers post-translational modifications and thus the formation of neo-antigens in type 1 diabetes, similar to the ones found in RA.

Methods

Collagen type II (CII), a known autoantigen in RA, was treated with ribose and various reactive oxygen species (ROS). Levels of antibodies specific to native and ROS-modified CII (ROS-CII) were compared in type 1 diabetes, type 2 diabetes and healthy controls, and related to the HLA genotype.

Results

Significantly higher binding to ROS-CII vs native CII was observed in type 1 diabetic patients possessing the HLA-DRB1*04 allele irrespective of variables of glucose control (blood glucose or HbA1c). Type 1 diabetic patients carrying a DRB1*04 allele with the shared epitope showed the highest risk for ROS-CII autoimmunity, while the DRB1*0301 allele was protective. Conversely, native CII autoimmunity was not associated with any specific DRB1 allele. Positive and inverse seroconversion rates of response to ROS-CII were high in DRB1*04-positive type 1 diabetic patients.

Conclusion

Hyperglycaemia and oxidative stress may trigger genetically controlled autoimmunity to ROS-CII and may explain the association between type 1 diabetes mellitus and RA.
Literature
1.
go back to reference Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300PubMedCrossRef Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300PubMedCrossRef
2.
3.
go back to reference Petrone A, Battelino T, Krzisnik C et al (2002) Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60:244–253PubMedCrossRef Petrone A, Battelino T, Krzisnik C et al (2002) Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60:244–253PubMedCrossRef
4.
go back to reference Thomson G, Valdes AM, Noble JA et al (2007) Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 70:110–127PubMedCrossRef Thomson G, Valdes AM, Noble JA et al (2007) Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 70:110–127PubMedCrossRef
5.
go back to reference Pihoker C, Gilliam LK, Hampe CS, Lernmark A (2005) Autoantibodies in diabetes. Diabetes 54(Suppl 2):S52–S61PubMedCrossRef Pihoker C, Gilliam LK, Hampe CS, Lernmark A (2005) Autoantibodies in diabetes. Diabetes 54(Suppl 2):S52–S61PubMedCrossRef
7.
go back to reference Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef
8.
go back to reference Griffiths HR (2008) Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev 7:544–549PubMedCrossRef Griffiths HR (2008) Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev 7:544–549PubMedCrossRef
9.
go back to reference Trigwell SM, Radford PM, Page SR et al (2001) Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus. Clin Exp Immunol 126:242–249PubMedCrossRef Trigwell SM, Radford PM, Page SR et al (2001) Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus. Clin Exp Immunol 126:242–249PubMedCrossRef
10.
go back to reference Khan MW, Banga K, Mashal SN, Khan WA (2011) Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications. BMC Immunol 12:19PubMedCrossRef Khan MW, Banga K, Mashal SN, Khan WA (2011) Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications. BMC Immunol 12:19PubMedCrossRef
11.
go back to reference Khan MW, Sherwani S, Khan WA, Ali R (2009) Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes. Autoimmunity 42:150–158PubMedCrossRef Khan MW, Sherwani S, Khan WA, Ali R (2009) Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes. Autoimmunity 42:150–158PubMedCrossRef
12.
go back to reference Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537–546PubMed Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537–546PubMed
13.
go back to reference Kim WUCM, Jung YO, Min SY, Park SW, Min DJ, Yoon JH, Kim HY (2004) Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci 327:202–211PubMedCrossRef Kim WUCM, Jung YO, Min SY, Park SW, Min DJ, Yoon JH, Kim HY (2004) Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci 327:202–211PubMedCrossRef
14.
go back to reference Kim WUYW, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY (2000) IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 3:575–581 Kim WUYW, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY (2000) IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 3:575–581
15.
go back to reference Nissim A, Winyard PG, Corrigall V et al (2005) Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum 52:3829–3838PubMedCrossRef Nissim A, Winyard PG, Corrigall V et al (2005) Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum 52:3829–3838PubMedCrossRef
16.
go back to reference Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33:197–207PubMedCrossRef Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33:197–207PubMedCrossRef
17.
go back to reference Liao KP, Gunnarsson M, Kallberg H et al (2009) Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum 60:653–660PubMedCrossRef Liao KP, Gunnarsson M, Kallberg H et al (2009) Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum 60:653–660PubMedCrossRef
18.
go back to reference Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5:151–157PubMedCrossRef Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5:151–157PubMedCrossRef
19.
go back to reference Petrone A, Giorgi G, Galgani A et al (2005) CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15:232–238PubMedCrossRef Petrone A, Giorgi G, Galgani A et al (2005) CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15:232–238PubMedCrossRef
20.
22.
go back to reference Rosario PW, Reis JS, Borges MA et al (2005) Extrapancreatic autoimmunity in patients with latent autoimmune diabetes of adults. Diabetes Care 28:496–497PubMedCrossRef Rosario PW, Reis JS, Borges MA et al (2005) Extrapancreatic autoimmunity in patients with latent autoimmune diabetes of adults. Diabetes Care 28:496–497PubMedCrossRef
23.
go back to reference Murao S, Kondo S, Ohashi J et al (2008) Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)–a 5-year follow-up of the Ehime study. Diabetes Res Clin Pract 80:114–121PubMedCrossRef Murao S, Kondo S, Ohashi J et al (2008) Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)–a 5-year follow-up of the Ehime study. Diabetes Res Clin Pract 80:114–121PubMedCrossRef
24.
go back to reference Triolo TM, Armstrong TK, McFann K et al (2011) Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 34:1211–1213PubMedCrossRef Triolo TM, Armstrong TK, McFann K et al (2011) Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 34:1211–1213PubMedCrossRef
25.
go back to reference Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380–386PubMedCrossRef Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380–386PubMedCrossRef
26.
go back to reference Baeten D, Peene I, Union A et al (2001) Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 44:2255–2262PubMedCrossRef Baeten D, Peene I, Union A et al (2001) Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 44:2255–2262PubMedCrossRef
27.
go back to reference Backlund J, Carlsen S, Hoger T et al (2002) Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 99:9960–9965PubMedCrossRef Backlund J, Carlsen S, Hoger T et al (2002) Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 99:9960–9965PubMedCrossRef
28.
go back to reference Mannering SI, Harrison LC, Williamson NA et al (2005) The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202:1191–1197PubMedCrossRef Mannering SI, Harrison LC, Williamson NA et al (2005) The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202:1191–1197PubMedCrossRef
29.
go back to reference Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F (2010) The type 1 diabetes-HLA susceptibility interactome—identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS One 5:e9576PubMedCrossRef Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F (2010) The type 1 diabetes-HLA susceptibility interactome—identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS One 5:e9576PubMedCrossRef
30.
go back to reference Queisser MA, Yao D, Geisler S et al (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59:670–678PubMedCrossRef Queisser MA, Yao D, Geisler S et al (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59:670–678PubMedCrossRef
31.
go back to reference Irigoyen P, Lee AT, Wener MH et al (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52:3813–3818PubMedCrossRef Irigoyen P, Lee AT, Wener MH et al (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52:3813–3818PubMedCrossRef
32.
go back to reference Verpoort KN, van Gaalen FA, van der Helm-van Mil AH et al (2005) Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058–3062PubMedCrossRef Verpoort KN, van Gaalen FA, van der Helm-van Mil AH et al (2005) Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058–3062PubMedCrossRef
33.
go back to reference Vay D, Vidali M, Allochis G et al (2000) Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients. Diabetologia 43:1385–1388PubMedCrossRef Vay D, Vidali M, Allochis G et al (2000) Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients. Diabetologia 43:1385–1388PubMedCrossRef
34.
go back to reference Festa A, Kopp HP, Schernthaner G, Menzel EJ (1998) Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41:350–356PubMedCrossRef Festa A, Kopp HP, Schernthaner G, Menzel EJ (1998) Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41:350–356PubMedCrossRef
35.
go back to reference Doyle HA, Mamula MJ (2002) Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 14:244–249PubMedCrossRef Doyle HA, Mamula MJ (2002) Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 14:244–249PubMedCrossRef
36.
go back to reference Lipponen K, Gombos Z, Kiviniemi M et al (2010) Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59:3253–3256PubMedCrossRef Lipponen K, Gombos Z, Kiviniemi M et al (2010) Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59:3253–3256PubMedCrossRef
37.
go back to reference Knip M, Korhonen S, Kulmala P et al (2010) Prediction of type 1 diabetes in the general population. Diabetes Care 33:1206–1212PubMedCrossRef Knip M, Korhonen S, Kulmala P et al (2010) Prediction of type 1 diabetes in the general population. Diabetes Care 33:1206–1212PubMedCrossRef
38.
go back to reference Barera G, Bonfanti R, Viscardi M et al (2002) Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 109:833–838PubMedCrossRef Barera G, Bonfanti R, Viscardi M et al (2002) Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 109:833–838PubMedCrossRef
39.
go back to reference Beyan H, Riese H, Hawa MI et al (2012) Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study. Diabetes 61:1192–1198PubMedCrossRef Beyan H, Riese H, Hawa MI et al (2012) Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study. Diabetes 61:1192–1198PubMedCrossRef
Metadata
Title
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus
Authors
R. Strollo
P. Rizzo
M. Spoletini
R. Landy
C. Hughes
F. Ponchel
N. Napoli
A. Palermo
R. Buzzetti
P. Pozzilli
A. Nissim
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2780-1

Other articles of this Issue 3/2013

Diabetologia 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.